Skip to Content

Levocarnitine Injection

Last Updated: May 20, 2015
Status: Resolved

Products Affected - Description

Levocarnitine injection, American Regent
200 mg/mL, 5 mL vials (NDC 00517-1045-25)

 
Levocarnitine injection, Teva
200 mg/mL, 5 mL vials (NDC 00703-0404-02) - discontinued
200 mg/mL, 12.5 mL vials (NDC 00703-0405-02) - discontinued

Reason for the Shortage

  • American Regent has levocarnitine injection on back order due to manufacturing delays. 
  • Teva has discontinued levocarnitine injection in late 2014.
  • West-Ward Pharmaceuticals’ parent company, Hikma Pharmaceuticals, acquired several products from Bedford Laboratories in July 2014 including levocarnitine injection. West-Ward is not actively marketing levocarnitine injection.

Available Products

Carnitor injection, Sigma Tau
200 mg/mL, 5 mL vials (NDC 54482-0147-01)

Estimated Resupply Dates

American Regent has levocarnitine injection on back order and the company cannot estimate a release date.

Related Shortages

Updated

May 20, March 18, January 12, 2015; November 12, August 28, May 28, February 26, January 15, 2014; October 14, August 5, May 22, April 19, February 13, 2013, December 12, October 12, 2012, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide